Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

OSLO, NORWAY - June 18, 2025: Microbiome DX company Genetic Analysis AS ("GA" or the "Company") hereby announces that the direct issue which was announced in a press release on the 05.05.2025 and approved by the Annual General Meeting on 19.05.2025 has now been registered with the Norwegian Register of Business Enterprises (No. Foretaksregisteret).

The directed issue provided the Company with approximately NOK 12.8 million by issuance of 14 890 576 new shares, before issue costs. The direct issue has now been registered with the Norwegian Register of Business Enterprises.

After this, the Company's new registered share capital is NOK 38 564 308,20 divided into 64 273 847 shares, each with a nominal value of NOK 0.60.

The Subsequent issue is still in the process of final allocation, payment and registration.